Truncated pStat5B is associated with the Idd4 locus in NOD mice

Biochemical and Biophysical Research Communications

Volumn 356, Issue 3, 2007, Pages 655-661

  Davoodi Semiromi, Abdoreza ^a   McDuffie, Marcia ^b   Litherland, Sally ^a   Clare Salzler, Michael ^a  

^a Department of Clinical and Health Psychology   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Autoimmune diseases; Constitutive; Diabetes; Idd4; JAK; NOD; Phosphorylation; Stat5B

Indexed keywords

DNA; JANUS KINASE; STAT5B PROTEIN;

ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CD4+ CD25+ T LYMPHOCYTE; CHROMOSOME 11; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; GENE; GENE LOCUS; IDD4 GENE; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MOUSE STRAIN; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE;

ANIMALS; ANTIGENS, CD4; DIABETES MELLITUS, TYPE 1; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; PEPTIDE FRAGMENTS; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 33947687696     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.028     Document Type: Article

References (28)

1. Schindler C., Shuai K., Prezioso V.R., and Darnell Jr. J.E. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257 (1992) 809-813
2. Levy D.E., and Darnell Jr. J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3 (2002) 651-662
3. Muller M., Briscoe J., Laxton C., Guschin D., Ziemiecki A., Silvennoinen O., Harpur A.G., Barbieri G., Witthuhn B.A., and Schindler C. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366 (1993) 129-135
4. Azam M., Erdjument-Bromage H., Kreider B.L., Xia M., Quelle F., Basu R., Saris C., Tempst P., Ihle J.N., and Schindler C. Interleukin-3 signals through multiple isoforms of Stat5. EMBO J. 14 (1995) 1402-1411
5. Caldenhoven E., van Dijk T.B., Raaijmakers J.A., Lammers J.W., Koenderman L., and de Groot R.P. Activation of a functionally distinct 80-kDa STAT5 isoform by IL-5 and GM-CSF in human eosinophils and neutrophils. Mol. Cell Biol. Res. Commun. 1 (1999) 95-101
6. McDuffie M. Derivation of diabetes-resistant congenic lines from the nonobese diabetic mouse. Clin. Immunol. 96 (2000) 119-130
7. Davoodi-Semiromi A., Laloraya M., Kumar G.P., Purohit S., Jha R.K., and She J.X. A mutant Stat5b with weaker DNA binding affinity defines a key defective pathway in nonobese diabetic mice. J. Biol. Chem. 279 (2004) 11553-11561
8. Galsgaard E.D., Gouilleux F., Groner B., Serup P., Nielsen J.H., and Billestrup N. Identification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene. Mol. Endocrinol. 10 (1996) 652-660
9. Azam M., Lee C., Strehlow I., and Schindler C. Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity 6 (1997) 691-701
10. Moriggl R., Gouilleux-Gruart V., Jahne R., Berchtold S., Gartmann C., Liu X., Hennighausen L., Sotiropoulos A., Groner B., and Gouilleux F. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell. Biol. 16 (1996) 5691-5700
11. Wang D., Stravopodis D., Teglund S., Kitazawa J., and Ihle J.N. Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16 (1996) 6141-6148
12. Bovolenta C., Testolin L., Benussi L., Lievens P.M., and Liboi E. Positive selection of apoptosis-resistant cells correlates with activation of dominant-negative STAT5. J. Biol. Chem. 273 (1998) 20779-20784
13. Nelson B.H. Interleukin-2 signaling and the maintenance of self-tolerance. Curr. Dir. Autoimmun. 5 (2002) 92-112
14. Todd J.A. Genetic analysis of susceptibility to type 1 diabetes Springer. Semin. Immunopathol. 14 (1992) 33-58
15. Burchill M.A., Goetz C.A., Prlic M., O'Neil J.J., Harmon I.R., Bensinger S.J., Turka L.A., Brennan P., Jameson S.C., and Farrar M.A. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J. Immunol. 171 (2003) 5853-5864
16. Davoodi-Semiromi A., Corps S., Litherland S.A., and Clare-Salzler M.J. Defective DNA binding of mutated Stat5B in regulatory T cells from NOD mice. Anonymous (2006), American Association of Immunologist Conference, Boston, MA
17. Murawski M.R., Litherland S.A., Clare-Salzler M.J., and Davoodi-Semiromi A. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis. Ann. N. Y. Acad. Sci. 1079 (2006) 198-204 198-204
18. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. (2005)
19. Gregori S., Giarratana N., Smiroldo S., and Adorini L. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol. 171 (2003) 4040-4047
20. Tang Q., Adams J.Y., Tooley A.J., Bi M., Fife B.T., Serra P., Santamaria P., Locksley R.M., Krummel M.F., and Bluestone J.A. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7 (2006) 83-92
21. Snow J.W., Abraham N., Ma M.C., Herndier B.G., Pastuszak A.W., and Goldsmith M.A. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J. Immunol. 171 (2003) 5042-5050
22. Laloraya M., Davoodi-Semiromi A., Kumar G.P., McDuffie M., and She J.X. Impaired crkl expression contributes to the defective DNA binding of stat5b in nonobese diabetic mice. Diabetes 55 (2006) 734-741
23. Salomon B., Lenschow D.J., Rhee L., Ashourian N., Singh B., Sharpe A., and Bluestone J.A. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
24. Reddy J., Waldner H., Zhang X., Illes Z., Wucherpfennig K.W., Sobel R.A., and Kuchroo V.K. Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 175 (2005) 5591-5595
25. Cohen A.C., Nadeau K.C., Tu W., Hwa V., Dionis K., Bezrodnik L., Teper A., Gaillard M., Heinrich J., Krensky A.M., Rosenfeld R.G., and Lewis D.B. Cutting edge: decreased accumulation and regulatory function of CD4+CD25high T cells in human STAT5b deficiency. J. Immunol. 177 (2006) 2770-2774
26. Xia Z., Sait S.N., Baer M.R., Barcos M., Donohue K.A., Lawrence D., Ford L.A., Block A.M., Baumann H., and Wetzler M. Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia. Leuk. Res. 25 (2001) 473-482
27. Mitchell T.J., Whittaker S.J., and John S. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary Syndrome. Cancer Res. 63 (2003) 9048-9054
28. Bovolenta C., Camorali L., Mauri M., Ghezzi S., Nozza S., Tambussi G., Lazzarin A., and Poli G. Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals. Clin. Immunol. 99 (2001) 75-81